James Richman
Profile
I lead OTLEN, where we build the AI infrastructure behind revenue operations for healthcare and biotech. Our systems connect clinical, financial and research data into a single operating core, so hospitals, clinic groups and life-science companies can see where value is lost and act on it early.
Record
- Role
- Chief Executive Officer, OTLEN
- Company
- AI-powered RevOps and RCM infrastructure for healthcare and biotech
- Founded
- 2008
- Headquarters
- San Francisco
- Based
- Singapore
- Previously
- Private investor, JJ Richman
01/Mission
Healthcare should spend its attention on patients and on research. Today too much of it goes into reconciling systems that were never designed to work together.
At OTLEN we treat that as an infrastructure problem, and we build AI agents that sit across the handoffs where revenue and time are lost.
Every claim, prior authorization, trial invoice and patient record passes through a chain of handoffs between people and systems. Each handoff is a place where value can leak. Our agents predict where those handoffs will fail and act early. Decisions that need clinical or financial judgment stay with people.
We serve two kinds of organizations. For health systems and biopharma, the work is unifying research, clinical and commercial data. For private clinic groups across Southeast Asia, it is revenue operations that run on their own.
02/OTLEN
OTLEN.
Founded in 2008, the company builds AI-powered RevOps and RCM infrastructure for healthcare and biotech enterprises.
- Founded
- 2008Founded
- Headquarters
- San FranciscoHeadquarters
- Based
- SingaporeWhere I am based
- Partner network
- Claude Partner NetworkInvited, June 2026
“We’re in the faulty wiring business.”
Mirror Review, September 2025
The platform connects EHR, revenue cycle and laboratory systems into one data core, uses AI models to predict revenue leakage and patient churn, and triggers the follow-up work automatically.
In June 2026 OTLEN was invited to join Anthropic’s Claude Partner Network, which extends how we deploy Claude-based agents across hospital systems and private clinics.
03/Principles
How I lead.
“When the ‘why’ is clear, you find the patience for any ‘how.’”
Mirror Review, September 2025
- (01)
Start with the patient and the clinician.
Every system we design begins with the person waiting for care and the person giving it.
- (02)
Judge AI by what it changes.
Revenue per patient, capacity used and leakage recovered are the measures we report on.
- (03)
Automate the handoffs, keep the judgment.
Agents carry the routine work between systems. People make the calls that need clinical or financial judgment.
- (04)
Build infrastructure for the long term.
Hospitals and research teams need systems they can rely on for a decade, and we design for that horizon.
04/Background
Background.
My path into healthcare ran through private investing.
Through my firm, JJ Richman, I spent years studying how organizations create value and where they lose it. The discipline that carried over into OTLEN is pattern recognition. I have Asperger’s, and it shapes how I see an organization: as a system of patterns first.
In 2024 my father fought cancer, and I lost him. Seeing the system from the family’s side made its cost personal, and it is a large part of why this work matters to me.
05/In the media
Selected coverage.
- AP News
- Yahoo Finance
- Benzinga
- Business Matters
- TechBullion
- Analytics Insight
- London Daily News
- Mirror Review
- StreetInsider
- USA Wire
- INSC Magazine
- Big News Network
Profiles, interviews, bylines and company announcements carried by these outlets, 2025 to 2026. The full list, with links, is under Public record.
In conversation.
“The real challenge, and opportunity, is finding the right balance between these agents and the human teams they support.”
USA Wire, June 2026
06/Timeline
Timeline.
2008
-
OTLEN is founded.
2025
- May
A USA Wire profile on AI in cancer research, after the loss of my father.
- Sep
OTLEN publishes The $350 Billion Bleed, its report on revenue cycle leakage.
- Sep
The Billion-Dollar Handoff, on the silos between biopharma research, clinical and commercial data.
- Sep
Profiles in Benzinga and Mirror Review.
- Oct
A biotech case study in TechBullion, a feature in Analytics Insight and a conversation with Business Matters.
2026
- Jan
A byline in TechBullion on AI revenue operations for Southeast Asian healthcare, and OTLEN’s announcement on AI for clinics.
- Jun
OTLEN is invited to join Anthropic’s Claude Partner Network.
- Jun
Interviews in USA Wire and INSC Magazine, and a profile in London Daily News.
Now
-
Chief Executive Officer of OTLEN, based in Singapore.
07/Public record
Public record.
- London Daily NewsOTLEN: James Richman’s mission to fix healthcare’s billion-pound bureaucracy, from personal heartbreak to high-tech crusadeProfile
- Big News NetworkJames Richman Says OTLEN Invited to Join Anthropic’s Claude Partner NetworkAnnouncement
- USA WireJames Richman on Balancing OTLEN’s Human Teams and AI AgentsInterview
- INSC MagazineOTLEN’s CEO James Richman Predicts AI Will Finally Give Ordinary People Fast and Fair HealthcareInterview
- Yahoo Finance, via ACCESS NewswirePatient Outcomes First: How James Richman’s OTLEN Brings AI to ClinicsAnnouncement
- TechBullionFrom Surgery to Ecosystem: How AI-Driven RevOps Is Lifting Patient Revenue 150–300% for Southeast Asia’s Healthcare LeadersByline
- Business MattersThe Balance Sheet and the Bedside: A Conversation with James Richman on Architecting a More Humane Healthcare SystemInterview
- TechBullionAnatomy of a Breakthrough: How OTLEN Helped One Biotech Cure Its Financial Chaos to Accelerate Its ScienceCase study
- Analytics InsightMaximizing ROI in Healthcare with the OTLEN Technology AdvantageFeature
- Mirror ReviewThe Quiet Revolutionary: How James Richman’s Methodical Leadership is Rebuilding Healthcare from the Inside OutProfile
- Big News NetworkThe $350 Billion Bleed: The OTLEN Report on the Hidden Costs of Revenue Cycle LeakageReport
- AP News, via GetNewsThe Billion-Dollar Handoff: Why Biopharma’s Biggest Risk Isn’t the Science, It’s the SilosPerspective
- BenzingaOtlen Challenges the AI Craze: Contrarian Investor’s Roadmap to True Biotech ValuePerspective
- USA WireCan AI Cure Cancer? James Richman Thinks So, and After Losing His Father, He’s All InProfile
- UndatedAP News, via GetNewsThe Invisible Tax: OTLEN’s James Richman on How Healthcare Inefficiency Is Stealing Time from FamiliesInterview
- UndatedStreetInsider, via Globe PR WireThe Systems Architect: How James Richman’s Mind for Patterns is Decoding Healthcare’s Financial ChaosProfile
08/Record
The record.
The same facts sit in this page’s code as a schema.org Person, so search engines can match the name to the right person. Several people share this name; this page is about the James Richman who leads OTLEN.
The work is the résumé.
This is an editorial starting point, designed to grow with original articles, projects, research, tools, examples, and case studies specific to this property.
I lead OTLEN from Singapore.